Lumos Pharma (LUMO)
NASDAQ:LUMO
US Market
Holding LUMO?
Track your performance easily

Lumos Pharma (LUMO) Financial Statements

349 Followers

Lumos Pharma Financial Overview

Lumos Pharma's market cap is currently ―. The company's EPS TTM is $-4.282; its P/E ratio is -1.01; Lumos Pharma is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 488.00K$ 165.00K$ 7.00K$ 527.00K$ 691.00K
Gross Profit$ 488.00K$ 165.00K$ 7.00K$ 527.00K$ 691.00K
EBIT$ -7.55M$ -10.44M$ -8.93M$ -8.96M$ -7.35M
EBITDA$ -7.55M$ -10.44M$ -8.92M$ -8.95M$ -7.34M
Net Income Common Stockholders$ -7.55M$ -10.44M$ -8.30M$ -8.93M$ -7.35M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 16.80M$ 23.20M$ 42.69M$ 50.85M$ 57.98M
Total Assets$ 21.36M$ 28.08M$ 47.75M$ 56.37M$ 63.73M
Total Debt$ 449.00K$ 518.00K$ 269.00K$ 346.00K$ 421.00K
Net Debt$ -16.35M$ -22.68M$ -42.42M$ -50.51M$ -57.56M
Total Liabilities$ 11.08M$ 10.64M$ 12.26M$ 12.71M$ 11.21M
Stockholders Equity$ 10.28M$ 17.44M$ 35.49M$ 43.66M$ 52.52M
Cash Flow-
Free Cash Flow$ -6.38M$ -12.89M$ -7.82M$ -6.68M$ -9.20M
Operating Cash Flow$ -6.38M$ -12.89M$ -7.82M$ -6.68M$ -9.20M
Investing Cash Flow-$ 1.00M$ 5.95M$ 1.08M$ -2.46M
Financing Cash Flow-$ -5.00K$ -435.00K$ -574.00K$ -309.00K
Currency in USD

Lumos Pharma Earnings and Revenue History

Lumos Pharma Debt to Assets

Lumos Pharma Cash Flow

Lumos Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis